secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocean Biomedical, Inc. (OCEA)
CIK:        0001869974
Form:       8-K
Filed at:   2023-09-06T23:59:59+00:00
Accession:  0001493152-23-031878
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve Nasdaq Proposal for share issuance from convertible notes and warrant
--------------------------------------------------------------------------------

- Special meeting held Aug 30, 2023; 25,756,950 shares present (~75.6% of 34,062,724 outstanding).
- Vote: 25,268,869 for, 472,508 against, 15,573 abstain on the Nasdaq Proposal.
- Proposal allows potential conversion of up to three Senior Secured Convertible Notes and warrant under May 15 SPA.
- Only one $7.56M note issued to date; ~24,400 shares issued for accrued interest; no warrant exercised.
- Full conversion of current note would equal ~2% of outstanding common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1869974/000149315223031878/0001493152-23-031878-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1869974/000149315223031878/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-031878

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer